Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy
about
Angiotensin receptors, autoimmunity, and preeclampsiaImmunoadsorption therapy for patients with dilated cardiomyopathy and heart failureAntibodies in the pathogenesis of hypertensionTargeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyNovel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat modelPotential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertensionPeripartum cardiomyopathy: challenges in diagnosis and management.Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized ratsAutoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosisCongenital heart disease linked to maternal autoimmunity against cardiac myosin.Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors.Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiographyAutoantibodies and cardiovascular dysfunction: cause or consequence?β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.The immunological basis of hypertensionAutoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathiesOpposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.Decreased autophagy in rat heart induced by anti-β1-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potentialAutoimmune hypertensive syndromeCellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.Receptor-activating autoantibodies and disease: preeclampsia and beyond.An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlationAutoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesisDecreased autophagy: a major factor for cardiomyocyte death induced by β1-adrenoceptor autoantibodies.Removal of pathogenic autoantibodies by immunoadsorption.Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapyAdoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant ratsRecent clinical and translational research on pediatric myocarditisProtective cardiovascular and renal actions of vitamin D and estrogenAutoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
P2860
Q24605647-0D79A34E-EBE0-4A2D-948F-C7DA137A09C6Q24652847-32DBDEF5-1725-4F9F-A529-6F0522390B0AQ26828588-D6441088-7555-4B92-A03E-1BA5377F9B27Q27000434-DBFCCA42-2EA5-4E63-A030-6B6D1FA97FB5Q27315858-60E8F044-F467-4859-BFED-F23A52D41A5CQ28575913-5A2B22D7-7014-46C8-B7FD-52AA92624CC3Q33363307-D0B5D5CC-5EFF-4BB1-A37B-37D30C5F1540Q33535920-D07D5296-025F-47FF-AECA-96B5EED73AB0Q33577570-299B40B5-6F79-4D98-BBD6-2DF319B57472Q33720002-332201D2-1C60-43D5-BFF4-999431C8EA14Q34035986-72BB153D-679E-48F1-AC2D-CA7E851D21CFQ34111376-FBA62623-1109-40DD-983B-7A83EAA83CF4Q34315311-196C77F9-C634-4392-9054-5C740F2E6F7EQ34364148-AC926E7B-519A-4808-8C2C-334356FF3B47Q34473885-2528B274-342E-4A45-92FA-892D4F2A0210Q34541400-412FEB28-68EF-4005-AB4D-47AF2ED34124Q34632155-6299EC66-AB4B-4D8C-9B1A-556451B759F3Q34683745-EBA844B0-952B-43AA-908F-B476F8B7336CQ35023544-CD1F14BD-D357-445B-9C27-9A401E4BE9A0Q35026108-4E2B7B6A-960E-4D48-A7C0-DA1377449184Q35026111-39E791B2-89CC-43EF-A718-6733511AFD3DQ35053981-2D53EB2B-AADA-45D0-8C25-75648593CC72Q35080102-68614FB0-F362-419F-95B8-1A169B075810Q35492692-7AABD991-4420-4B25-85F2-299D16FC2DBEQ35707881-8625CC59-64A0-418D-ACE0-4A24E2FD63B6Q35720141-71C789B8-7436-4671-8DCD-F79345D0633BQ35774994-82679E6B-C506-4AA5-AC32-55E5D6681401Q35868721-D27574C4-81F4-4FE8-A0F3-2EB874BC36FDQ36022333-035F113D-9FD7-444D-9877-C5C7A090801AQ36242884-2AF7D6CA-3DB0-4C41-83D9-B21FF7707A6AQ36259538-AD250947-D67C-4021-BBD9-27E1060F9E45Q36647124-C7AFF991-4B14-42D2-94AD-B4BBCCD81956Q36665715-36DBF560-A931-436A-927F-C2A47C1B11D1Q36683260-66B4D936-F1D5-4715-B816-1CA859D4DFDBQ36829646-2A5A0D83-B3E8-49C1-899F-0A77A286ADE1Q36905627-337285DD-06C3-45B7-B51D-D57DED7794D8Q36971570-A3AF6A13-9A60-45CC-98D4-EBCABBB85D98Q37004826-06C5B692-8DB8-4442-96C1-2B636394B4C0Q37008467-F7EE6358-2C30-4616-B053-6DD6EF7F1BC0Q37051232-DB58D095-C098-4D3A-BF9F-640ECA3DF209
P2860
Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy
@en
type
label
Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy
@en
prefLabel
Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy
@en
P2093
P2860
P356
P1476
Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy
@en
P2093
Christiane E Angermann
Georg Ertl
Roland Jahns
Sven Triebel
Valérie Boivin
P2860
P304
P356
10.1172/JCI200420149
P407
P577
2004-05-01T00:00:00Z